Literature DB >> 679543

Medial collateral ligament injuries of the knee: a rationale for treatment.

J F Fetto, J L Marshall.   

Abstract

Isolated MCL I and MCL II lesions evidence good recovery of integrity and function under non-operative modes of treatment. Isolated MCL III lesions may also be treated by non-operative management, but with the expectation of a slightly less successful result. However, there is an 80% incidence of concomitant ligament injury with this grade of lesion. The prognosis following injury to the MCL is significantly influenced by the presence of concurrent compromise of other ligaments, particularly that of the anterior cruciate ligament. Resolution of knee instability and dysfunction following a mixed MCL injury of any grade severity is best accomplished through operative intervention. Therefore, it is the authors' opinion that isolated MCL III and all mixed MCL lesions are best managed with operative treatment. Because of the apparent influence compromise of other ligament structures have on the recovery of MCL function, an attempt must be made to repair all acutely injured structures at the time of surgery. The keystones of a satisfactory result are early and accurate diagnosis, prompt treatment, and when indicated, complete surgical repair.

Entities:  

Mesh:

Year:  1978        PMID: 679543

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  59 in total

1.  Consideration of growth factors and bio-scaffolds for treatment of combined grade II MCL and ACL injury.

Authors:  Natasha Anoka; John Nyland; Mark McGinnis; Dave Lee; Mahmut Nedim Doral; David N M Caborn
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-08-10       Impact factor: 4.342

2.  Single allograft medial collateral ligament and posterior oblique ligament reconstruction: a technique to improve valgus and rotational stability.

Authors:  Jiangtao Dong; Gang Ji; Yingze Zhang; Shijun Gao; Fei Wang; Baicheng Chen
Journal:  Eur J Orthop Surg Traumatol       Date:  2013-06-27

Review 3.  MCL injuries of the knee: current concepts review.

Authors:  Phinit Phisitkul; Stan L James; Brian R Wolf; Annunziato Amendola
Journal:  Iowa Orthop J       Date:  2006

4.  Sartorial branch of the saphenous nerve in relation to a medial knee ligament repair or reconstruction.

Authors:  Coen A Wijdicks; Benjamin D Westerhaus; Emily J Brand; Steinar Johansen; Lars Engebretsen; Robert F LaPrade
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2009-10-27       Impact factor: 4.342

5.  Surgical management of grade 3 medial knee injuries combined with cruciate ligament injuries.

Authors:  Hideyuki Koga; Takeshi Muneta; Kazuyoshi Yagishita; Young-Jin Ju; Ichiro Sekiya
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-05-10       Impact factor: 4.342

Review 6.  Medial collateral ligament injuries in athletes.

Authors:  B Reider
Journal:  Sports Med       Date:  1996-02       Impact factor: 11.136

7.  Bioinspired Scaffold Designs for Regenerating Musculoskeletal Tissue Interfaces.

Authors:  Mohammed A Barajaa; Lakshmi S Nair; Cato T Laurencin
Journal:  Regen Eng Transl Med       Date:  2019-12-17

8.  Incarceration of the medial collateral ligament in the intercondylar notch following proximal avulsion.

Authors:  Edward Walton; Martin Williams; James R Robinson
Journal:  Skeletal Radiol       Date:  2017-07-20       Impact factor: 2.199

Review 9.  Clinical assessment of antero-medial rotational knee laxity: a systematic review.

Authors:  Dinesh Sirisena; Enrica Papi; Eleanor Tillett
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-10-27       Impact factor: 4.342

10.  Simultaneous surgical management of chronic grade-2 valgus instability of the knee and anterior cruciate ligament deficiency in athletes.

Authors:  Leonardo Osti; Rocco Papalia; Angelo Del Buono; Franco Merlo; Vincenzo Denaro; Nicola Maffulli
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2009-10-17       Impact factor: 4.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.